An Act specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law

This bill sets limits on over-the-counter sales of pseudoephedrine (PSE) products, like cold medicines, directly affecting pharmacies and customers purchasing these items. It requires pharmacies to verify customer ID, log purchases, and use a free, real-time electronic tracking system starting January 2026 to prevent sales exceeding daily (3.6g) or monthly (9g) limits. The system must block sales that would violate these limits and include an emergency override for staff fearing immediate harm, which is logged. The law also preempts local regulations and makes violations misdemeanors with fines up to $5,000 for repeat offenses.